Pacific Software Inc. is a skin care and medical aesthetics company, which engages in developing, producing, and marketing online internet sales portals to facilitate ecommerce between countries. The company is headquartered in Wakefield, Massachusetts. The company went IPO on 2010-12-06. The firm's clinical pipeline includes neuroprotective compounds that restore neuronal functions and can address multiple clinical indications with significant unmet patient needs. The firm is focused on a 4P Medicine platform, in strategic partnership with SpectroChip Global Inc., for early detection and intervention of conditions before irreversible damage occurs. The firm operates under a Health Canada issued Controlled Drugs and Substances License. The company has developed a pipeline of proprietary formulations and novel small molecules (NCEs). The firm's pipeline includes PUR100 Series and PUR500 Series.
P/E (price / listing EPS) Forward revenue growth (NTM) 
